🇺🇸 FDA
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

56 results for “AVIR” Clear

  1. efavirenz, emtricitabine and tenofovir alafenamide

    EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL approved

  2. elvitegravir

    GENVOYA

    ORAL approved

    J05AR

  3. elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide

    ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    approved

  4. entecavir

    BARACLUDE Amneal Pharma Europe Ltd

    ORAL approved

    J05AF10

  5. etravirine

    INTELENCE Amneal Pharma Europe Ltd

    ORAL approved

    J05AG04

  6. fosamprenavir

    TELZIR

    J05AE07

  7. fosamprenavir calcium

    FOSAMPRENAVIR CALCIUM

    ORAL approved

  8. fostemsavir

    RUKOBIA

    J05AX

  9. fostemsavir tromethamine

    RUKOBIA

    ORAL approved

  10. human papillomavirus 9-valent vaccine (recombinant, adsorbed)

    GARDASIL 9

    J07BM03

  11. human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)

    CERVARIX

    J07BM02

  12. human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)

    GARDASIL

    J07BM01

  13. indinavir

    CRIXIVAN

    J05AE02

  14. indinavir sulfate

    CRIXIVAN

    ORAL approved

  15. ledispavir

    HARVONI

    J05AX65

  16. lenacapavir

    SUNLENCA

    SUBCUTANEOUS approved

    J05AX31

  17. lenacapavir sodium

    SUNLENCA

    SUBCUTANEOUS approved

  18. lopinavir

    KALETRA

    ORAL approved

    J05AR10

  19. maraviroc

    CELSENTRI

    ORAL approved

    J05AX09

  20. maribavir

    LIVTENCITY Takeda Pharmaceuticals International AG

    ORAL approved

    J05AX10

  21. molnupiravir

    LAGEVRIO

    J05A

  22. nelfinavir

    VIRACEPT

    J05AE04

  23. nelfinavir mesylate

    VIRACEPT

    ORAL approved

  24. raltegravir

    ISENTRESS

    J05AJ01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources